BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Tokai Pharmaceuticals 



Boston  Massachusetts    U.S.A.
Phone: Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Tokai Pharmaceuticals (TKAI) Presents Updated Interim Galeterone ARMOR2 Data Showing Activity In Patients With Castration-Resistant Prostate Cancer (CRPC) Including Those Showing A Variant Form Of Prostate Cancer Resistant To Hormone Therapy 11/19/2014 11:18:15 AM
Tokai Pharmaceuticals (TKAI) To Ring The Nasdaq Stock Market Opening Bell 11/14/2014 10:18:39 AM
Tokai Pharmaceuticals (TKAI) Reports Third Quarter 2014 Financial Results 11/10/2014 10:19:55 AM
Tokai Pharmaceuticals (TKAI) To Present At Upcoming Healthcare Investor Conferences 11/4/2014 10:19:32 AM
Tokai Pharmaceuticals (TKAI) Announces Closing Of Initial Public Offering 9/24/2014 12:04:40 PM
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering 9/17/2014 9:19:42 AM
Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO 9/17/2014 7:38:06 AM
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer 9/2/2014 11:17:46 AM
Tokai Pharmaceuticals Appoints Daniel T. Dransfield, Ph.D. As Vice President, Head Of Translational Medicine 8/27/2014 8:59:59 AM
Tokai Pharmaceuticals, Chasing The Field In Prostate Cancer, Files For $75 Million IPO 8/12/2014 7:23:11 AM
1234